A new form of gene therapy shows promise in battling recurrent brain cancer. The phase 1 clinical trial included 56 patients with recurrent high-grade glioma brain cancer. Three years after the gene therapy treatment, more than a quarter of the patients were still alive. Median survival for patients was 14.4 months, compared with eight months… [...]
PLYMOUTH MEETING, PA—The opioid epidemic is clearly one of the top public health concerns in the country. Rarely, though, do news stories address the safety risks from opioids used by patients in hospitals. Despite the focus on appropriate use of opioids for pain management, many hospitals continue to see adverse events in which patients are [...]
PLYMOUTH MEETING, PA—Improving the accuracy of patient identification remains a challenge across all healthcare settings. Misidentifications occur during every aspect of care from registration to discharge and beyond, based on evidence analyzed by ECRI Institute PSO in its recently completed Deep Dive analysis of over 7,600 safety events related to patient identification. These errors impact patient [...]
PLYMOUTH MEETING, PA—Safe implementation of new technologies and therapies accompany classic patient safety challenges on ECRI Institute's 2017 Top 10 Patient Safety Concerns for Healthcare Organizations. The report highlights concerns from health information management, clinical decision support, and new oral anticoagulants to long-standing concerns like test result reporting and follow-up and unrecognized patient deterioration. ECRI Institute [...]
© Copyright | Pennsylvania Association for Healthcare Quality | All Rights Reserved | Privacy Policy | Managers
